FDA Clearance Tracker · P020007
MEDTRONIC AVE BRIDGE EXTRA SUPPORT OVER THE WIRE RENAL STENT SYSTEM
Last checked: Nov 20, 2026Latest source record: Dec 18, 2002 (this decision)Source: openFDAMethods & limitations
Decided
Dec 18, 2002
Approval withdrawn
Time to decision
306 days
Received Feb 15, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P020007
- Device name
- MEDTRONIC AVE BRIDGE EXTRA SUPPORT OVER THE WIRE RENAL STENT SYSTEM
- Applicant
- Medtronic Vascular
- Applicant location
- Santa Rosa, CA
- Received
- Feb 15, 2002
- Decided
- Dec 18, 2002
- Decision
- Approval withdrawn
- Expedited review
- Yes, flagged as expedited in FDA's record.
- Supplements
- 1 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- STENT, RENAL (NIN)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE MEDTRONIC AVE BRIDGE EXTRA SUPPORT OVER-THE-WIRE (OTW) RENAL STENT SYSTEM. THE DEVICE IS INDICATED FOR USE IN PATIENTS WITH ATHEROSCLEROTIC DISEASE OF THE RENAL ARTERIES FOLLOWING SUB-OPTIMAL OR FAILED PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY (PTRA) OF A DE NOVO LESION (<=15 MM IN LENGTH) LOCATED WITHIN 10 MM OF THE AORTORENAL BORDER AND WITH A REFERENCE VESSEL DIAMETER OF 5.0 TO 7.0 MM. SUB-OPTIMAL OR FAILED PTRA INCLUDE ANY OF THE FOLLOWING: VISIBLE EVIDENCE OF A RESIDUAL STENOSIS >=50% AFTER OPTIMAL PTRA, VISIBLE EVIDENCE OF INTIMAL DISSECTION >6 MM, OR PEAK SYSTOLIC TRANS-STENOTIC GRADIENT OF >=20 MM HG OR A MEAN OF >=10 MM HG.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NIN. The earliest in FDA's data is P890017, decided Sep 27, 1991.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Medtronic Vascular
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K232570 · Decided Oct 24, 2023 · 61 days after receipt
Device type: Wire, Guide, Catheter (DQX) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.